Assignee
ABLYNX NV
BE·127 granted patents·97 pending applications·563 citations·filing 2002–2025
Top patents by PatentIndex Score
224 records- 0199US11485777B2Immunoglobulin variable domainsABLYNX NV·Filed 2021·Granted Nov 1, 2022·8 cites·16 claims
- 0299US11485778B2Immunoglobulin variable domainsABLYNX NV·Filed 2021·Granted Nov 1, 2022·7 cites·10 claims
- 0399US11319364B2Immunoglobulin variable domainsABLYNX NV·Filed 2021·Granted May 3, 2022·8 cites·13 claims
- 0499US11312765B2Immunoglobulin variable domainsABLYNX NV·Filed 2021·Granted Apr 26, 2022·9 cites·15 claims
- 0599US11220539B2Immunoglobulin variable domainsABLYNX NV·Filed 2020·Granted Jan 11, 2022·9 cites·23 claims
- 0698US11708404B2Immunoglobulin variable domainsABLYNX NV·Filed 2022·Granted Jul 25, 2023·4 cites·14 claims
- 0797US11753465B2Nucleic acids encoding polypeptides against IL-23ABLYNX NV·Filed 2021·Granted Sep 12, 2023·3 cites·12 claims
- 0897US11312764B2Immunoglobulin variable domainsABLYNX NV·Filed 2019·Granted Apr 26, 2022·10 cites·19 claims
- 0997US10858418B2Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2020·Granted Dec 8, 2020·18 cites·20 claims
- 1097US7807162B2Single domain VHH antibodies against von Willebrand factorABLYNX NV·Filed 2006·Granted Oct 5, 2010·72 cites·6 claims
- 1195US11142569B2Serum albumin-binding immunoglobulin variable domainsABLYNX NV·Filed 2016·Granted Oct 12, 2021·10 cites·11 claims
- 1295US10968271B2Polypeptides against IL-23ABLYNX NV·Filed 2016·Granted Apr 6, 2021·9 cites·8 claims
- 1395US9067991B2Nanobodies against tumor necrosis factor-alphaABLYNX NV·Filed 2014·Granted Jun 30, 2015·21 cites·19 claims
- 1494US11426468B2Cysteine linked nanobody dimersABLYNX NV·Filed 2015·Granted Aug 30, 2022·14 cites·6 claims
- 1594US11208476B2Polypeptides comprising immunoglobulin single variable domains targeting IL-13 and TSLPABLYNX NV·Filed 2021·Granted Dec 28, 2021·12 cites·12 claims
- 1694US9745372B2TNF bindersABLYNX NV·Filed 2017·Granted Aug 29, 2017·18 cites·2 claims
- 1793US11332519B2Serum albumin bindersABLYNX NV·Filed 2016·Granted May 17, 2022·7 cites·18 claims
- 1893US11009511B2Methods for detecting and/or measuring anti-drug antibodies, in particular treatment-emergent anti-drug antibodiesABLYNX NV·Filed 2015·Granted May 18, 2021·6 cites·7 claims
- 1993US10927186B2T cell recruiting polypeptides based on TCR alpha/beta reactivityABLYNX NV·Filed 2016·Granted Feb 23, 2021·19 cites·20 claims
- 2093US10844123B2Amino acid sequences that modulate the interaction between cells of the immune systemABLYNX NV·Filed 2018·Granted Nov 24, 2020·4 cites·25 claims
- 2193US10087251B2Amino acid sequences that modulate the interaction between cells of the immune systemABLYNX NV·Filed 2016·Granted Oct 2, 2018·9 cites·21 claims
- 2293US9683045B2Biological materials related to c-MetABLYNX NV·Filed 2014·Granted Jun 20, 2017·17 cites·12 claims
- 2393US9346884B2Biological materials related to c-MetABLYNX NV·Filed 2012·Granted May 24, 2016·15 cites·5 claims
- 2492US11332525B2Polypeptides comprising immunoglobulin single variable domains targeting TNFA and IL-23ABLYNX NV·Filed 2021·Granted May 17, 2022·4 cites·14 claims
- 2592US11192937B2Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2017·Granted Dec 7, 2021·5 cites·6 claims
- 2692US11192938B2Serum albumin binding proteins containing immunoglobulin single variable domainsABLYNX NV·Filed 2017·Granted Dec 7, 2021·5 cites·35 claims
- 2792US10550174B2Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseasesABLYNX NV·Filed 2017·Granted Feb 4, 2020·6 cites·20 claims
- 2892US10544211B2TNF bindersABLYNX NV·Filed 2016·Granted Jan 28, 2020·14 cites·4 claims
- 2992US8962805B2Anti IL-6R polypeptides and compositions thereofABLYNX NV·Filed 2014·Granted Feb 24, 2015·14 cites·19 claims
- 3091US11414481B2Serum albumin bindersABLYNX NV·Filed 2018·Granted Aug 16, 2022·6 cites·22 claims
- 3191US9969805B2Amino acid sequences directed against HER2 and polypeptides comprising the same for the treatment of cancers and/or tumorsABLYNX NV·Filed 2015·Granted May 15, 2018·10 cites·20 claims
- 3291US9834595B2Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseasesABLYNX NV·Filed 2015·Granted Dec 5, 2017·6 cites·10 claims
- 3391US9273150B2Methods of using IL-6R antibodies to block or reduce binding of IL-6 to IL-6RABLYNX NV·Filed 2014·Granted Mar 1, 2016·11 cites·16 claims
- 3490US12516105B2Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2021·Granted Jan 6, 2026·1 cites·9 claims
- 3590US9181350B2Nucleic acids encoding IL-6R-binding polypeptidesABLYNX NV·Filed 2014·Granted Nov 10, 2015·10 cites·23 claims
- 3690US8372398B2Single domain VHH antibodies against Von Willebrand FactorABLYNX NV·Filed 2010·Granted Feb 12, 2013·14 cites·12 claims
- 3789US11897951B2Polypeptides comprising immunoglobulin single variable domains targeting IL-6 and TNF-αABLYNX NV·Filed 2021·Granted Feb 13, 2024·3 cites·18 claims
- 3889US10208115B2Amino acid sequences that modulate the interaction between cells of the immune systemABLYNX NV·Filed 2016·Granted Feb 19, 2019·5 cites·25 claims
- 3989US9605072B2Nucleic acids that encode interleukin-6 receptor binding polypeptidesABLYNX NV·Filed 2014·Granted Mar 28, 2017·8 cites·42 claims
- 4089US9265834B2Stable formulations of polypeptides and uses thereofABLYNX NV·Filed 2013·Granted Feb 23, 2016·8 cites·25 claims
- 4189US2024182575A1Amino acid sequences that modulate the interaction between cells of the immune systemABLYNX NV·Filed 2023·Application pending·0 cites
- 4288US12180268B2Immunoglobulin variable domainsABLYNX NV·Filed 2015·Granted Dec 31, 2024·2 cites·10 claims
- 4388US11840566B2Methods of treating asthma with polypeptides targeting IL-13 and TSLPABLYNX NV·Filed 2021·Granted Dec 12, 2023·1 cites·18 claims
- 4488US11384151B2CX3CR1-binding polypeptides comprising immunoglobulin single variable domainsABLYNX NV·Filed 2019·Granted Jul 12, 2022·2 cites·11 claims
- 4588US9611326B2Interleukin-6 receptor binding polypeptidesABLYNX NV·Filed 2013·Granted Apr 4, 2017·7 cites·22 claims
- 4687US12553901B2Methods for detecting and/or measuring anti-drug antibodies, in particular treatment-emergent anti-drug antibodiesABLYNX NV·Filed 2021·Granted Feb 17, 2026·1 cites·10 claims
- 4787US11932702B2Polypeptides comprising immunoglobulin single variable domains targeting glypican-3 and T cell receptorABLYNX NV·Filed 2021·Granted Mar 19, 2024·3 cites·28 claims
- 4887US11046767B2T cell recruiting polypeptides based on CD3 reactivityABLYNX NV·Filed 2016·Granted Jun 29, 2021·5 cites·17 claims
- 4987US9617341B2Methods for blocking or reducing binding of interleukin-6 to interleukin-6 receptorABLYNX NV·Filed 2014·Granted Apr 11, 2017·7 cites·34 claims
- 5087US9371381B2Single domain antibodies directed against tumor necrosis factor-alpha and uses thereforABLYNX NV·Filed 2014·Granted Jun 21, 2016·5 cites·16 claims
Showing the top 50 of 224 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →